Generate a tailored SOP for Dr. Mike Nutt. Improve your application with a focused, well-structured draft.
Mike Nutt is a PhD student and Research Fellow at the University of Western Australia, focusing on Medicinal Chemistry and drug development. His research centers on developing thalidomide derivatives as potential agents for treating liver cancer, employing innovative synthetic methodologies including novel rhodium II-catalyzed reactions. His work aims to create a library of structurally diverse thalidomide analogues, which will be assessed for their ability to selectively inhibit liver cancer cell proliferation. With a global health impact, liver cancer ranks as the fifth most common cancer and a leading cause of cancer-related deaths. Current treatment options are limited and associated with significant toxicity, thus Nutt's research seeks to enhance drug selectivity, contributing to the development of safer, more effective therapeutic agents. He has received the Ernest Evelyn Havill-Schacklock Scholarship for his postgraduate research endeavors and has taught several chemistry courses at his university, contributing to higher education in the field. His active projects include the synthesis and biological evaluation of new structural analogues for various therapeutic applications.
University of Western Australia • Perth
Investigating thalidomide derivatives for liver cancer treatment.
Requirements are standardized across the Graduate School for most Master by Coursework programs at UWA.